BlackRock’s Neurotrope, Inc. Common NTRP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-65,492
| Closed | -$73K | – | 5250 |
|
|
2020
Q3 | $73K | Sell |
65,492
-1,088
| -2% | -$1.25K | ﹤0.01% | 4559 |
|
|
2020
Q2 | $76K | Buy |
66,580
+16,529
| +33% | +$20.7K | ﹤0.01% | 4527 |
|
|
2020
Q1 | $40K | Sell |
50,051
-1,611
| -3% | -$1.76K | ﹤0.01% | 4518 |
|
|
2019
Q4 | $51K | Sell |
51,662
-358
| -0.7% | -$279 | ﹤0.01% | 4538 |
|
|
2019
Q3 | $42K | Sell |
52,020
-8,021
| -13% | -$36.8K | ﹤0.01% | 4560 |
|
|
2019
Q2 | $482K | Buy |
60,041
+35,464
| +144% | +$238K | ﹤0.01% | 4195 |
|
|
2019
Q1 | $134K | Buy |
24,577
+3,729
| +18% | +$16K | ﹤0.01% | 4326 |
|
|
2018
Q4 | $75K | Sell |
20,848
-384
| -2% | -$2.33K | ﹤0.01% | 4408 |
|
|
2018
Q3 | $187K | Buy |
21,232
+864
| +4% | +$8.27K | ﹤0.01% | 4328 |
|
|
2018
Q2 | $198K | Buy |
20,368
+2,420
| +13% | +$22.3K | ﹤0.01% | 4306 |
|
|
2018
Q1 | $147K | Sell |
17,948
-455
| -2% | -$3.61K | ﹤0.01% | 4271 |
|
|
2017
Q4 | $129K | Buy |
18,403
+728
| +4% | +$4.24K | ﹤0.01% | 4297 |
|
|
2017
Q3 | $92K | Sell |
17,675
-1,001
| -5% | -$5.25K | ﹤0.01% | 4374 |
|
|
2017
Q2 | $175K | Buy |
+18,676
| New | +$199K | ﹤0.01% | 4286 |
|
Other funds holding NTRP
BlackRock's NTRP Position: Q4 2020 in Review
BlackRock sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 65,492 shares — an estimated $73K sold.
BlackRock first reported a position in NTRP in Q2 2017 and held it in 14 quarters. The position peaked at $482K in Q2 2019. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.
- BlackRock reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
- BlackRock sold 65,492 Neurotrope, Inc. Common shares in Q4 2020, an estimated $73K.
- BlackRock first reported a position in Neurotrope, Inc. Common in Q2 2017 and held it in 14 quarters.
- BlackRock's Neurotrope, Inc. Common position peaked at $482K in Q2 2019.
- 1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.
Based on BlackRock's 13F filing for Q4 2020, filed 5 Feb 2021.